Conference Announcements

CIS 2018

Clinical Immunology Society (CIS) 2018 Annual Meeting

Thu, 26 Apr 2018 – Sun, 29 Apr 2018

On behalf of the Clinical Immunology Society (CIS), we invite you to attend the 2018 Annual Meeting: Immune Deficiency and Dysregulation North American Conference taking place April 26 – 29, 2018 at The Sheraton Centre Toronto in Toronto, Canada.

           CIS is the key inter-disciplinary organization for the field of clinical immunology and is devoted to fostering developments in the science and practice of clinical immunology. The mission of CIS is to facilitate education, translational research and novel approaches to therapy in clinical immunology and to promote excellence in the care of patients with immunologic/inflammatory disorders.

Abstract submission for the 2018 CIS Annual Meeting will open on September 12, 2017. Notification of selected Abstracts will take place in mid-January 2018.

The Annual Meeting and Update in PID pre-conference will provide a venue for the presentation of the newest immune deficiency diseases and the pathogenesis of these defects in molecular terms. The substance of the conference will be cutting edge clinical and basic science research.

Join us for this momentous occasion that promises to be one of the best conferences on primary immunodeficiency. We look forward to seeing you in Toronto!


Abstract submission is now open. Below is more information regarding submissions for the 2018 Annual Meeting.

The Annual Meeting will provide a venue for the presentation of the newest immune deficiency diseases and the pathogenesis of these defects in molecular terms.

  • Abstracts submissions are collected through the online submission page only; e-mailed abstracts or any other form of submission will not be accepted.
  • Submitters are able to upload graphs and/or charts through the submission system.
  • Abstract submission will close December 20, 2017. All abstracts must be submitted in full by 11:59 pm CDT on December 20 to be considered.
  • Notification of selected Abstracts will take place in mid-to-late January.

Session Information

The 2018 Update in PID pre-conference and the Annual Meeting will feature different presentations selected from submitted abstracts. This years conference will feature the following:

  • Oral Abstracts
  • Posters
  • Lightning Poster Presentations

Submitted abstracts may be programmed into any part of the Annual Meeting, including the Update in PID pre-conference.

Topics of Interest

CIS invites all Members and non-members to submit an abstract for review for the 2018 CIS Annual Meeting. The following is a list of categories of interest to CIS for abstract submission. This is not an inclusive list and abstracts on categories not listed will also be accepted.

  •     B cell biology
  •     Biological mechanisms of PID
  •     Hematopoietic cell transplantation and gene therapy
  •     Immune dysregulation in PID
  •     Immune modulating therapies
  •     Immunoglobulin replacement therapy
  •     Infections in PIDs
  •     Innate immunity
  •     NK cell biology
  •     Novel genetic etiologies of PIDs
  •     Phenotypic and molecular spectrum of Primary Immune Deficiency
  •     PID registries
  •     T cell biology
  •     Other topics related to clinical immunology

Important Dates

September 2017
Abstract Submission Opens

October 2, 2017
Housing Opens

October 11, 2017
Registration Opens

December 20, 2017
Abstract Submission Closes

February 9, 2018
Early Bird Registration Closes

March 23, 2018
Housing Closes

March 30, 2018
Online Registration Closes


Clinical Immunology Society
Conference Website:
Sheraton Centre Hotel

123 Queen St W, ON M5H 2M9
Toronto, Toronto